EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (Annals of the Rheumatic Diseases, 2017)

(untitled) - Smolen, J; Landewé, R; Bijlsma, J; Burmester, G; Chatzidionysiou, K; Dougados, M; Nam, J; Ramiro, S; Voshaar, M; van Vollenhoven, R; Aletaha, D; Aringer, M; et al.